Updates on COVID-19 Treatment Recommendations

On January 26th, 2023, the FDA announced that Evusheld is no longer authorized for emergency use in the United States. Please visit the FDA’s website and view ASPR’s information sheet for additional details.

Outpatient antiviral treatments for COVID-19, including oral antivirals (OAVs) and IV remdesivir (Veklury), effectively reduce the risk of hospitalization and death. Nirmatrelvir with ritonavir (Paxlovid) is the preferred treatment for most outpatients or remdesivir if Paxlovid is contraindicated. The oral antiviral molnupiravir (Lagevrio) is authorized as an alternative when Paxlovid and remdesivir are not accessible or clinically appropriate. (NIH COVID-19 Treatment Guidelines for Non-Hospitalized Adults) The antivirals Paxlovid, remdesivir, and molnupiravir are expected to be active against circulating subvariants.

Categories: PulsePublished On: January 27th, 2023Tags: , ,

Share

Related Posts

  • Health Commerce System – New Enhancements and Security Features

    Health Commerce System – New Enhancements and Security Features The Department of Health is updating its Health Commerce System (HCS) to enhance security and improve user experience. Starting May 9th, 2024, you’ll see improvements to our “Forgot Password” feature and login interface. For further details and assistance, click here.  

  • DEA Announces Move to Reclassify Marijuana from Schedule I to Schedule III

    DEA Announces Move to Reclassify Marijuana from Schedule I to Schedule III Colleagues: On April 30, the DEA announced a move to reclassify Marijuana from Schedule I to Schedule III, alongside Ketamine and some anabolic steroids. This would recognize the use of medical marijuana and make it easier to conduct research, but marijuana would not […]

  • LaughMD App Pioneers Laughter as Billable, Scalable, Evidence-based Medicine

    LaughMD App Pioneers Laughter as Billable, Scalable, Evidence-based Medicine LaughMD is improving the approach to healthcare and wellness in hospitals, dialysis clinics and oncology facilities, bringing laughter right to the bedside of patients and into the daily routines of healthcare staff. With a powerful blend of clinical research and innovative technology, LaughMD offers a unique solution to combat […]

  • California and Oregon Push Toward Universal Healthcare

    California and Oregon Push Toward Universal Healthcare California and Oregon, in response to the federal healthcare policy gridlock, have taken significant steps toward establishing universal healthcare coverage. These states have enacted laws that mandate creating publicly financed, universal coverage systems. These reforms promise substantial cost savings and improved healthcare access for all residents. However, the […]